摘要
目的探讨子宫剖宫产瘢痕妊娠的有效治疗方法。方法对2006年1月至2009年8月我院收治的36例子宫剖宫产瘢痕妊娠患者的临床资料进行回顾性分析。结果胎囊大小及血β-人绒毛膜促性腺激素(β-HCG)的测定对治疗方案的选择及调整有很大指导意义,药物治疗中,甲氨蝶呤(MTX)胎囊内局部注射与全身序贯治疗效果相近,对于胎囊直径<15 mm、血β-HCG<10 000 mIU/ml的患者采用MTX治疗是有效的,胎囊直径≥15 mm、血β-HCG>10 000 mIU/ml的患者采用MTX治疗效果欠佳,两组比较差异有统计学意义(P<0.01)。结论早期诊断是成功治疗子宫剖宫产瘢痕妊娠的关键,对于胎囊较小、β-HCG较低的患者采用药物治疗是安全有效的,对于胎囊较大β-HCG较高的患者可尝试药物治疗,但需有进一步有效的治疗措施作为二线治疗。
Objective To research better methods for diagnosing and treating cesarean scar pregnancy. Methods We retrospectively analyze the clinical data of 36 patients with cesarean scar pregnancies that were admitted to our hospital between January 2006 and August 2009.Results Fetal sac and HCG was a guide for the choice to therapy for the cesarean scar pregnancies.Conclusion Early diagnosis is the key for successful treatment of cesarean scar pregnancy.MTX systemic therapy is safe and effective in well-selected patients with lower HCG.
出处
《临床医学》
CAS
2010年第6期36-38,共3页
Clinical Medicine
